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ABSTRACT: Rapid and speciﬁc detection of single nucleotide
polymorphisms (SNPs) related to drug resistance in infectious
diseases is crucial for accurate prognostics, therapeutics and
disease management at point-of-care. Here, we present a novel
ampliﬁcation method and provide universal guidelines for the
detection of SNPs at isothermal conditions. This method, called
USS-sbLAMP, consists of SNP-based loop-mediated isothermal
ampliﬁcation (sbLAMP) primers and unmodiﬁed self-stabilizing
(USS) competitive primers that robustly delay or prevent
unspeciﬁc ampliﬁcation. Both sets of primers are incorporated
into the same reaction mixture, but always targeting diﬀerent
alleles; one set speciﬁc to the wild type allele and the other to the
mutant allele. The mechanism of action relies on thermodynamically favored hybridization of totally complementary primers,
enabling allele-speciﬁc ampliﬁcation. We successfully validate our method by detecting SNPs, C580Y and Y493H, in the
Plasmodium falciparum kelch 13 gene that are responsible for resistance to artemisinin-based combination therapies currently
used globally in the treatment of malaria. USS-sbLAMP primers can eﬃciently discriminate between SNPs with high sensitivity
(limit of detection of 5 × 101 copies per reaction), eﬃciency, speciﬁcity and rapidness (<35 min) with the capability of
quantitative measurements for point-of-care diagnosis, treatment guidance, and epidemiological reporting of drug-resistance.
The emergence of drug resistance is a constant threat toglobal public health, limiting the ability to treat infectious
diseases eﬀectively and compromising medical procedures.1
Rapid detection of single nucleotide polymorphisms (SNPs)
that are linked with resistance phenotypes in infectious
pathogens is, therefore, key to improving treatment eﬃcacy
and guiding clinical usage of drugs toward development of
personalized medicine. However, the detection of genetic
markers is still a major challenge for molecular-based
diagnostic technologies, especially for those aiming to be
deployed at point-of-care (PoC).
Currently, high-throughput methods such as Next Gen-
eration Sequencing or Sanger sequencing are considered the
gold standard for low frequency allele detection. Despite their
advancement in the past decade, their high cost and time to
report results limit their use outside specialized laboratories.2,3
A variety of PCR-based methods have been developed to
enhance detection of genetic markers. These allele-speciﬁc
PCR (AS-PCR) techniques can be classiﬁed into two main
groups: major allele suppression methods and minor allele
enrichment methods. Within the ﬁrst group, blocking primers
have been designed to suppress the ampliﬁcation of the major
allele, enabling minor allele ampliﬁcation by allele-speciﬁc
primers. Diﬀerent approaches have been reported such as (i)
PCR blocking primers with a poly-A tail of four nucleotides4 or
with 3′ end modiﬁcations (ddNTPs, carbon-spacer, or inverted
DNA nucleotides),5−7 (ii) PCR clamping6 based on the
incorporation of peptide nucleic acids,8 bridged nucleic acids,9
or locked nucleic acids,10 or (iii) PCR ampliﬁcation of
previously treated DNA with lambda exonuclease.11 Within the
second group, AS-PCR techniques have focused on enhancing
the ampliﬁcation of the minor allele12 by the incorporation of
(i) primers speciﬁc to the SNP at their 3′ end,13 (ii) primers
with mismatches within the four bases from the 3′ end,14,15 or
(iii) primers of diﬀerent lengths for melting temperature (Tm)
analysis.16 However, the need of thermal cycling, gel
electrophoresis,17 and modiﬁed oligonucleotides for validation
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elevate the time and cost per sample, preventing these PCR-
based methods from being widespread to decentralized areas.
An alternative to PCR is isothermal DNA ampliﬁcation
techniques, which oﬀer nucleic acid synthesis at constant
temperature using simpler and less complex equipment better
suited to applications at PoC. Several isothermal techniques
have been reported, each one with its own innovative
characteristics and temperature requirements in the range of
30−65 °C, depending on the enzymes used in the reaction.
The most popular techniques are (i) recombinase polymerase
ampliﬁcation,18 (ii) nucleic acid sequence-based ampliﬁca-
tion,19 (iii) loop-mediated isothermal ampliﬁcation (LAMP),20
and (iv) helicase-dependent ampliﬁcation.21 Among them,
LAMP has become popular due to advantages such as its high
eﬃciency, high ampliﬁcation yield, high speciﬁcity due to four
to six primers in the reaction, strand displacement DNA
synthesis between 60 and 65 °C, and the capability of visual
detection of products due to precipitation of magnesium
pyrophosphate.22,23 Allele-speciﬁc LAMP (AS-LAMP) has
been previously described for minor allele ampliﬁcation.
Several approaches have been reported such as (i) placing
the SNP at the 5′ end of overlapped FIP and BIP primers,24,25
(ii) placing the SNP at the 3′ end of B2 or LB primer,26 or (iii)
introducing additional mismatches.27,28 These methods either
delay the onset of the unspeciﬁc reaction, or the time-to-
positive (TTP) of the speciﬁc reaction is too late such that
their applicability is limited to test high concentrated samples.
Each design is unique and target dependent, preventing their
standardization across other relevant SNPs. The addition of
universal QProbe29 or the utilization of the Taq Mut enzyme30
have addressed this to an extent, however, the need of melting
analysis, complex primer design, or low speciﬁcity prevent the
use of these methods at the PoC.
Here, we describe a new method and propose universal
primer design guidelines for enhanced SNP detection at
isothermal conditions based on (i) SNP-based loop-mediated
isothermal ampliﬁcation (sbLAMP) primers, which consist of
six primers targeting eight diﬀerent regions, with two of them
responsible for AS-LAMP ampliﬁcation, and (ii) the novel
unmodiﬁed self-stabilizing (USS) competitive primers, com-
plementary to the SNP at their 5′ end, which are responsible
for robustly delaying or preventing unspeciﬁc sbLAMP
ampliﬁcation. In contrast to conventional blocking PCR
primers, which present 3′ end modiﬁcations, the proposed
USS primers are chemically unmodiﬁed with capability to
extend (higher stability) and compete with other primers and
intermediate ampliﬁed structures in the reaction. We
demonstrate successful application of our method, deﬁning
universal primer design guidelines based on the detection of
the SNP C580Y located in the gene kelch 13 (K13) of the AT-
rich genome of P. falciparum responsible for resistance to
artemisinin-based drug treatment of malaria.31,32 As validation,
the same principles were used to develop USS-sbLAMP
primers for detection of another antimalarial-resistant K13
SNP, Y493H. The proposed method has shown high
sensitivity, eﬃciency, speciﬁcity and rapid TTP (<35 min)
for SNP detection, and it is also applicable to mixed
populations. The primer design guidelines we provide at the
end of each section aim to give a foundation for the design of
new USS-sbLAMP primer sets for the detection of other
relevant targets. Diagnostic tests incorporating the proposed
isothermal chemistry will greatly expand the capability of rapid
SNP screening, including in limited-resource settings (LRS)
where rapid, sensitive, and speciﬁc diagnostics of infectious
diseases are of vital importance.
■ EXPERIMENTAL SECTION
Primer Design of USS-sbLAMP Speciﬁc to SNP C580Y
and SNP Y493H. The USS-sbLAMP method consists of a
total of eight primers targeting ten distinct regions of the DNA
template. The sbLAMP primer set is composed of two outer
primers (F3 and B3), two loop primers (LF and LB) and two
inner primers (sbFIP and sbBIP), where F1c and B1c locate
the SNP at their 5′ end. The USS primer set consists of a
forward blocking competitive primer (FB) and a backward
blocking competitive primer (BB). The USS-sbLAMP primer
sets for the speciﬁc detection of C580Y and Y493H were
designed based on the gene K13 of P. falciparum. Consensus
reference genomic sequences from all human-infective
Plasmodium species (PF3D7_1343700.1, PFIT_1342900,
PKNH_1257700, PKNOH_S09541100, PVP01_1211100,
PVX_083080, PmUG01_12021200, POcGH01_12019400)
were retrieved from Plasmodium Genomic Resource (Plas-
moDB)33 and aligned using MUSCLE algorithm34 in Geneious
10.0.5 software.35 The sbLAMP primer set was designed using
Primer Explorer V5 (Eiken Chemical Co. Ltd., Tokyo, Japan;
http://primerexplorer.jp/lampv5e/index.html) and optimized
manually to locate the SNP at the 5′ end of F1c and B1c,
following the method described by Eiken Chemical Co., Ltd.,24
with the novelty of considering the local GC% composition for
the design of FIP and BIP primers, named as sbFIP and sbBIP.
Diﬀerent lengths of F1c and B1c were designed for the SNP
C580Y (17 bp, 19 bp, 21 bp, and 25 bp for F1c, and 21 bp, 25
bp, 27 bp, and 29 bp for B1c) and for the SNP Y493H (21 bp
for F1c and 17 bp for B1c). The USS primer sets were
designed based on the most suitable pair of F1c and B1c for
allele-speciﬁc ampliﬁcation based on experimental data (see
Results and Discussion). FB and BB primers of diﬀerent
lengths were manually designed, always equal or longer than
the selected F1c and B1c. They were between 0 and 6 bp
longer at the 3′ end (additional 0 to −3.93 kcal/mol−1) and
locate the SNP within the 3 bp (up to −1.31 kcal/mol−1)
closer to their 5′ end (FB0, FB1, FB2 and BB0, BB1 and BB2),
where the number indicates the position of the SNP from the
5′ end. To investigate the performance of the competitive
primers, reverse-complementary primers to FB/BB, named
FA/BA, were designed, and 3′ end modiﬁcations (/3AmMo/)
were added to each primer set, named FA*/BA* and FB*/
BB*. All primers used in this paper can be found in Table S1
and ﬁnal USS-sbLAMP primer sets in Table S2.
USS-sbLAMP Mechanism. The incorporation of USS
primers in the sbLAMP reaction enhances allele discrimination
by preventing unspeciﬁc sbLAMP ampliﬁcation (caused by
unspeciﬁc sbLAMP primers) through thermodynamically
favored hybridization to the template due to total comple-
mentarity and self-stabilizing capability. USS primers and
sbFIP/sbBIP primers (within sbLAMP) are in the same
reaction mixture but always targeting diﬀerent alleles, one set
speciﬁc to the wild type (WT) allele and the other to the
mutant (MT) allele. Allelic discrimination is possible by
comparing the outcome of two independent reactions: WT
reaction (sbLAMPWT and USSMT primers) and MT reaction
(sbLAMPMT and USSWT primers), as shown in Scheme 1.
sbLAMP follows the LAMP method described by Notomi et
al.20 It is initiated by the binding of two inner primers sbFIP
(F1c-F2) and sbBIP (B1c-B2), which bind to F2c and B2c
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regions, respectively, leaving F1c and B1c free. Two outer
primers F3 and B3 displace the strands, releasing single-
stranded DNA (ssDNA). The free F1c and B1c form a
dumbbell-like structure by annealing to their complementary
sequences F1 and B1, respectively. It is rapidly linearized from
its 3′ end, and the binding of sbFIP and sbBIP initiate the
cyclic ampliﬁcation step. During this step, LF and LB primers
bind their complementary sequences, which are in between
B1c and B2c and F1 and F2, further accelerating the reaction.36
The complementarity of the USS primers to the target
template (with SNP speciﬁcity) suggests the possibility of
hybridization during the initiation stage of sbLAMP, causing a
general delay in speciﬁc and unspeciﬁc reactions until USS
primers are displaced by F3/B3 and sbFIP/sbBIP (F2 and B2,
speciﬁcally). At the end of the initiation stage, the annealing of
the USS primers to the template and the formation of the
dumbbell-like structure with the binding of sbFIP and sbBIP
cannot occur simultaneously. Consequently, there will be a
competition and the most energetically favorable reaction, the
speciﬁc reaction, will occur at a ﬁrst stage. In case that the
DNA template is not speciﬁc to the sequence of the USS
primers, they may anneal, but the 5′ end will be unbound
leaving a toehold for loop formation and subsequent
ampliﬁcation by speciﬁc sbLAMP primers. If the DNA
template is speciﬁc to the sequence of the USS primers, a
second stage will take place. The association between the USS
primers and the template is not transient and a highly stable
primer-template complex is formed as nucleotides are
incorporated by the DNA polymerase. FB will anneal to the
B1 region of the dumbbell-like structure preventing the
annealing between B1 and B1c regions of this structure (this
3′ end cannot act as a primer) and the annealing of B2 of the
BIP primer to the B2c region of the dumbbell-like structure;
BB will anneal to the F1 region of the dumbbell-like structure
preventing the annealing between F1 and F1c regions of this
structure (this 3′ end cannot act as a primer) and the annealing
of F2 of the FIP primer to the F2c region of the dumbbell-like
structure. This self-stabilizing behavior will create byproducts
that do not prime ampliﬁcation and, therefore, will inhibit the
formation of dumbbell-like structures preventing unspeciﬁc
ampliﬁcation.
The hybridization energies of speciﬁc FB/BB must be
favorable with respect to the energies of unspeciﬁc F1c/B1c,
ΔG°(F1c/B1c) > ΔG°(FB/BB). To achieve that, the design of USS
primers followed two principles: primer elongation along the
3′ end and displacement of the position of the SNP from their
5′ end. Regarding the ﬁrst principle, FB/BB primers should be
equal or longer than F1c/B1c. Overlapping with the 5′ end of
LF and LB must be minimum (1−2 bp) and preferably
avoided, although it might be tolerated since only one of the
USS primers will be slightly compromised (some mismatches
with the template, although it might be able to bind because
the region is free) when preventing the formation of the
dumbbell structure. Since USS primers should not delay the
TTP, their free energy values should not exceed in more than
10 kcal mol−1 the free energy values of F1c/B1c. Regarding the
second principle, placing the SNP slightly away from the 5′
end of USS primers might enhance their speciﬁcity due to the
fact that a local region around the SNP will be opened or
closed based on their complementarity at the SNP position.
Depending on the sequence of the target, placing the SNP at
their 5′ end could be the most optimum conﬁguration.
Thermodynamic Calculations of USS-sbLAMP Pri-
mers. Possible secondary structures, primer dimer formation,
and hybridization stability were checked using NUPACK37 and
NetPrimer (Premier Biosoft, NetPrimer; https://www.
premierbiosoft.com/netprimer/). Equations38−40 can be
found in Table S3 and obtained ΔG° values in Tables S4,
S7, S9, and S11.
Samples and DNA Extraction Methods. Two gBlock
Gene fragments of 607 bp were purchased from Integrated
DNA Technologies (Table S2) and resuspended in TE buﬀer
to 5 ng/μL stock solutions (stored at −20 °C). The WT
synthetic DNA template (named here as WT template)
contained SNPs 580C and 493Y; the MT synthetic DNA
template (named here as MT template) contained the
corresponding drug-resistant mutations, 580Y and 493H. P.
falciparum genomic DNA (gDNA) was isolated using the
PureLink Genomic DNA Mini Kit (ThermoFisher Scientiﬁc)
from Cambodian and Thai culture adapted asexual parasites
harboring the WT K13 allele (ANL1 and ARN1G,
respectively), a Thai isolate harboring K13 539T mutation
(APS2G), a Cambodian isolate containing K13 493H mutation
(ANL8G), and a Cambodian isolate with K13 580Y mutation
(ANL5G). P. ovale curtisi, P. ovale wallikeri, P. vivax, P.
malariae, and P. knowlesi clinical isolates (gDNA) were kindly
provided by Prof. Colin Sutherland. The samples were stored
at −20 °C until experiments were performed.
USS-sbLAMP Reaction Conditions. Two independent
reactions, WT reaction and MT reaction, were performed with
each target. Each reaction mixture contained the following: 1.5
μL of 10× isothermal buﬀer, 0.9 μL of MgSO4 (100 mM
stock), 2.1 μL of dNTPs (10 mM stock), 0.375 μL of BSA (20
mg/mL stock), 2.4 μL of Betaine (5 M stock), 0.375 μL of
SYTO 9 Green (20 μM stock), 0.6 μL of Bst 2.0 DNA
polymerase (8,000 U/mL stock), 3 μL of diﬀerent
Scheme 1. Mechanism of USS-sbLAMP in the Presence of
Mutant DNAa
aAs an example, mutant (MT) DNA presents allele A and it is
uniquely ampliﬁed within the MT reaction (sbLAMPMT and USSWT
primers). Ampliﬁcation of the MT DNA within the wild type (WT)
reaction (sbLAMPWT and USSMT primers) is signiﬁcantly delayed or
prevented by the annealing of complementary USSMT primers to the
template.
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concentrations of synthetic DNA or gDNA, 1.5 μL of 10×
sbLAMP primer mixture (20 μM sbBIP/sbFIP, 10 μM LF/LB,
and 2.5 μM B3/F3), and enough nuclease-free water
(ThermoFisher Scientiﬁc) to bring the volume to 15 μL. All
reagents were purchased to New England BioLabs and all
synthetic DNA to Integrated DNA Technologies. Reactions
were performed at 63 °C for 50 min for screening purposes
and 30−35 min for ﬁnal assays. For high resolution melting,
SYTO 9 Green was replaced by EvaGreen (Biotium,
California) at a ﬁnal concentration of 0.6 μM and one cycle
was performed at 95 °C for 60 s, 40 °C for 60 s, 65 °C for 1 s,
and 97 °C for 1 s (Figure S1). Experiments were performed
twice, and each condition was run in triplicates (5 μL each
reaction) loading the reactions into LightCycler 480 Multiwell
Plates 96 (Roche Diagnostics) utilizing a LightCycler 96 Real-
Time PCR System (Roche Diagnostics). Competitive primers
(FA/BA, FA*/BA*, FB/BB, or FB*/BB*) were incorporated
into the sbLAMP 10× primer mixture at diﬀerent ﬁnal
concentrations: 1, 1.5, 2, 2.5, 3, 3.5, 4, and 4.5 μM. Nuclease-
free water was adjusted to bring the volume to 15 μL. sbLAMP
and USS primers were purchased from Integrated DNA
Technologies and resuspended in nuclease-free water to 100
and 400 μM stock solutions, respectively. The solutions were
stored at 4 °C.
Figure 1. Results of sbLAMP using diﬀerent F1c-B1c primer lengths. (A) Comparison of WT template (580C) ampliﬁcation by WT speciﬁc
(sbLAMPWT) and MT speciﬁc (sbLAMPMT) primer sets with diﬀerent lengths of F1c and B1c. (B) Comparison of MT template (580Y)
ampliﬁcation by WT speciﬁc (sbLAMPWT) and MT speciﬁc (sbLAMPMT) primer sets with diﬀerent lengths of F1c and B1c. (C) Table showing the
ΔTTP values between speciﬁc and unspeciﬁc primer sets. Average TTP values of speciﬁc reactions below 20 min are blue shadowed. ΔTTP values
above 2 min are orange colored. Average of two experiments performed in triplicates using 5 × 104 copies/reaction of synthetic DNA. Selected
sbLAMP primer sets are indicated with arrows in the plots and dark blue cells in the table.
Figure 2. Incorporation of USS primer for enhancement of sbLAMP. (A) Performance comparison of USS primers with diﬀerent lengths added to
sbLAMP reaction at 2 μM/reaction for detecting SNP C580Y. A total of 15 diﬀerent combinations were tested. Selected USS primers are indicated
with arrows (****p-value). (B) Performance comparison of redesigned USS primers added to sbLAMP reaction at 2 μM/reaction for detecting
SNP C580Y. A total of 9 diﬀerent combinations were tested. Selected USS primers are indicated by arrows (****p-value). (C) Comparison of
modiﬁed, unmodiﬁed and reverse competitive primers for allele-speciﬁc detection (WT template in the upper section, and MT template in the
lower section). (D, E) Optimisation of the concentration of USS primers (FB/BB). WT template (580C) in (D) and MT template (580Y) in (E).
Selected concentrations for the detection of SNP C580Y are labeled by arrows, USSMT at 4 μM and USSWT at 3 μM. Average of two experiments
performed in triplicates using 5 × 104 copies/reaction of synthetic DNA. Negative control (NC), no addition of USS primers.
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Sensitivity of USS-sbLAMP Method. Sensitivity was
evaluated using 10-fold serial dilutions of synthetic DNA: 5 ×
104, 5 × 103, 5 × 102, and 5 × 101 copies/reaction. Standard
curves were generated by plotting the TTP against copies/
reaction with errors at one standard deviation. Sensitivity of
mixed populations was evaluated by spiking synthetic DNA
harboring the WT allele and the MT allele at diﬀerent ratios
(100/0, 80/20, 50/50. 20/80, and 0/100, in percentages) from
stock solution at 2.5 × 103 copies/reaction.
Cross-Reactivity of USS-sbLAMP Method and Detec-
tion of Clinical Isolates. Ten clinical isolates (gDNA) were
used to evaluate the feasibility of USS-sbLAMP and to prove
the absence of cross-reactivity with any other human-infective
Plasmodium species. Samples included P. ovale curtisi, P. ovale
wallikeri, P. vivax, P. malariae, P. knowlesi (2 samples), P.
falciparum harboringWT K13 alleles (2 samples), P. falciparum
harboring the MT allele 580Y, 493H, and 539T allele (3
diﬀerent samples). Experiments were performed as described
above.
Statistical Analysis. Data is presented as mean TTP ±
standard deviation; p-values were calculated by Student’s
heteroscedastic t-test, with a two-sided distribution. Statisti-
cally signiﬁcant diﬀerence was considered as *p-value < 0.05,
**p-value < 0.01, ***p-value < 0.001, ****p-value < 0.0001;
k-means cluster analysis and ANOVA test were performed in
Origin software (OriginLab, Northampton, MA).
■ RESULTS AND DISCUSSION
sbLAMP Method. Diﬀerent lengths of F1c and B1c were
designed in order to study the impact of local GC% content,
Tm and primer length in (i) allele-speciﬁcity and (ii) TTP. The
design of overlapping primers for allele detection is not trivial,
and the dissimilarity of the sequence in terms of ACTG
composition upstream and downstream the position of the
SNP should be taken into account. In general, primers are
equal in length (23−24 bp)24 and are considered speciﬁc and
stable as long as they present optimal GC% content and Tm to
anneal to the DNA template.41 Due to the fact that the GC%
content and Tm are diﬀerent at local regions with respect to the
position of the SNP, allele-speciﬁc primers sbFIP and sbBIP
might be of diﬀerent lengths. F1c and B1c of four diﬀerent
lengths each (Table S1) were designed with hybridization
energies considered between −10.00 and −23.00 kcal mol−1
(Table S4), increasing proportionally to the length of the
primers and the GC%. Real-time ampliﬁcation experiments of
WT (Figure 1A) and MT (Figure 1B) templates were
performed independently. Two independent reactions, WT
speciﬁc (sbLAMPWT) and MT speciﬁc (sbLAMPMT), were
tested with each template. A total of 16 combinations of F1c-
B1c were performed; F1c of 17, 19, 21, and 25 bp and B1c of
21, 25, 27, and 29 bp. For both DNA templates, the TTP of
speciﬁc and unspeciﬁc reactions was reduced as B1c was
elongated from 21 to 29 bp, and allele-speciﬁc detection was
enhanced as F1c was shortened from 25 to 17 bp.
The ampliﬁcation time diﬀerence (ΔTTP) between speciﬁc
and unspeciﬁc reactions with each template is presented in
Figure 1C. Detailed TTP values of all reactions are reported in
Table S5. The results in Figure 1 showed the existence of a
critical length for B1c (>27 bp) at which the TTP was
signiﬁcantly reduced (highlighted in blue). Two highly
signiﬁcant clusters were obtained by performing k-means
cluster analysis and ANOVA test of sbLAMP results of WT
and MT templates (P > F = 4.44 × 10−15 and P > F = 1.53 ×
10−14, respectively). The selected sbLAMP primer sets
according to the highest ΔTTP were F1c17-B1c27 for both
alleles (indicated by arrows in Figure 1A,B, and dark blue cells
in Figure 1C).
Guideline 1. Allele-speciﬁcity and TTP were signiﬁcantly
enhanced by modifying the length of F1c and B1c with respect
to the standard sizes. It is recommended to design allele-
Figure 3. Standard curves of speciﬁc USS-sbLAMP reactions for detection of SNP C580Y and SNP Y493H. (A) USS-sbLAMP ampliﬁcation of
serially diluted WT template (580C) and MT template (580Y), in the upper and lower section, respectively. (B) USS-sbLAMP ampliﬁcation of
serially diluted WT template (493Y) and MT template (493H), in the upper and lower section, respectively. (C) Table showing the TTP values of
WT and MT reactions with WT or MT template independently. Reactions were considered negative above 30 min for C580Y and above 35 min for
Y493H. Average of two experiments performed in triplicates.
Table 1. Study of the USS-sbLAMP Method in Mixed
Populations Harbouring SNPs C580Y and Y493Ha
spiked DNA
WT/MT (%)
WT reaction 580C
TTP ± SD (min)
MT reaction 580Y
TTP ± SD (min)
100/0 15.6 ± 0.6 NEG
80/20 15.9 ± 0.7 19.5 ± 0.9
50/50 16.2 ± 0.7 19.1 ± 0.2
20/80 16.7 ± 0.9 18.6 ± 0.4
0/100 NEG 18.1 ± 0.4
spiked DNA
WT/MT (%)
WT reaction 493Y
TTP ± SD (min)
MT reaction 493H
TTP ± SD (min)
100/0 23.0 ± 1.9 NEG
80/20 23.7 ± 1.4 22.8 ± 1.3
50/50 24.4 ± 1.9 21.1 ± 1.8
20/80 25.9 ± 1.9 20.4 ± 1.8
0/100 NEG 20.0 ± 1.5
aSpiked mixed populations at diﬀerent ratios (100/0, 80/20, 50/50,
20/80, and 0/100, in percentages) from stock at 2.5 × 103 copies/
reaction. Average of two experiments performed in triplicates.
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speciﬁc primers of diﬀerent lengths depending on the GC%
content at the local region. Shortening the primer that sits at
the richer GC% region proved to enhance allele-speciﬁcity
(preferably not less than 13 bp, i.e. −8.52 kcal mol−1).
Elongating the primer that sits at the richer AT% region with
respect to the other primer equalized their free energy values
and Tm (even favoring the primer that sits at the richer AT%
region) such that both primers performed properly (early
TTP). For optimal performance (allele-speciﬁcity and early
TTP) more than 15 bp diﬀerence (−9.83 kcal mol−1) between
F1c and B1c should be avoided.
Incorporation of USS Primers for Enhancement of
sbLAMP. USS primers were incorporated into the sbLAMP
reaction at 2 μM to prevent unspeciﬁc sbLAMP ampliﬁcation.
FB and BB of diﬀerent lengths (FB of 27, 29, 31, and 33 bp
and BB of 17, 19, 21, and 23 bp) were designed (Table S1)
and a total of 15 diﬀerent combinations were tested. Real-time
ampliﬁcation experiments of WT and MT templates were
performed independently. Two independent reactions, WT
reaction (sbLAMPWT and USSMT), and MT reaction
(sbLAMPMT and USSWT), were tested with each template.
The TTP of speciﬁc reactions are shown in the lower section
of Figure 2A and the TTP of unspeciﬁc reactions in the upper
section. Detailed TTP values can be found in Table S6. As the
length of USS primers is increased unspeciﬁc reactions are
signiﬁcantly delayed, while speciﬁc reactions are slightly
delayed. Consequently, there is a trade-oﬀ between allele-
speciﬁcity and sensitivity. The length of BB had a higher
impact on the delay of both reactions than the length of FB.
This behavior might be attributed to the richer GC% content
of the BB region and hence, the free energy hybridization
values (Table S7). In general, USS primers must be within an
optimal length range, and results of both templates, WT and
MT, must be interpreted as a whole to select the most suitable
USS primer set. The criterion for the selection of the most
optimal size of FB/BB was based on (i) minimizing the TTP of
the speciﬁc reactions and (ii) maximizing the TTP of the
unspeciﬁc reactions. Because both criteria cannot be fulﬁlled
by any USS primer set, a balance is considered as the optimal.
The selected lengths were USSWT FB27/BB21 and USSMT FB33/
BB21. The ΔTTP between speciﬁc and unspeciﬁc reactions was
statistically signiﬁcant (****p-value) for both templates, WT
and MT.
To enhance allele-speciﬁcity, the selected FB/BB primers
were redesigned to locate the SNP at three diﬀerent positions
from their 5′ end (5′X···3′ named as FB0/BB0, 5′NX···3′
named as FB1/BB1, and 5′NNX···3′ named as FB2/BB2
where X denoted the SNP) by adding nucleotides totally
complementary to the DNA template (Table S1). A total of
nine diﬀerent combinations were tested. Detailed TTP values
can be found in Table S8. According to the estimated free
energy values presented in Table S9, as far as the SNP is
displaced away from the 5′ end, the speciﬁc hybridization is
favored due to enhanced primer stability (additional −0.66 to
−1.31 kcal mol−1). However, the risk of creating an internal
bulge between unspeciﬁc USS primers and the DNA template
prevents to locate the SNP far from the third position (i.e.,
FB2/BB2) from the 5′ end of FB/BB primers. TTP of speciﬁc
reactions were not signiﬁcantly aﬀected by the incorporation of
the redesigned USS primers. However, unspeciﬁc reactions
were further delayed, contributing to allele-speciﬁc detection.
Based on the experimental results obtained in Figure 2B the
selected redesigned primers were USSWT FB127/BB221 and
USSMT FB233/BB121. The ΔTTP between speciﬁc and
unspeciﬁc reactions was statistically signiﬁcant (****p-value)
for both templates, WT and MT.
Guideline 2. The nucleotide sequence of FB/BB primers is
restricted by the template, and their length is limited by the 5′
end of LF and LB primers. It is recommended that USS
primers are between 0 to 8 bp longer than F1c/B1c primers
(additional 0 to −5.24 kcal mol−1) with GC clamps at their 3′
end, if possible, to favor their stability upon hybridization.
Locating the SNP within the three base pairs closer to their 5′
end (preferably FB1/BB1 or FB2/BB2, meaning an additional
−0.66 to −1.31 kcal mol−1) favor speciﬁc hybridization to their
target template. Placing the SNP more than 4 bp (additional
−2.62 kcal mol−1) away the 5′ end should be avoided due to
the high risk of internal bulges formation and unspeciﬁc
ampliﬁcation.
Comparison of Modiﬁed, Unmodiﬁed, and Reverse
Competitive Primers. Based on the selected USSWT FB127/
BB221 and USSMT FB233/BB121 primers, their reverse-comple-
ment and the addition of 3′ end modiﬁcations were studied.
Table 2. Cross-Validation of the USS-sbLAMP Method for Detection of SNP C580Y and SNP Y493a
sample
WT reaction 580C
TTP ± SD (min)
MT reaction 580Y
TTP ± SD (min)
WT reaction 493Y
TTP ± SD (min)
MT reaction 493H
TTP ± SD (min)
Pan-P
TTP ± SD (min)
580C1 17.8 ± 0.2 NEG 26.3 ± 1.4 NEG 10.5 ± 0.7
580C2 16.7 ± 0.1 NEG 25.0 ± 1.6 NEG 9.2 ± 0.4
580Y NEG 18.5 ± 0.6 25.9 ± 1.8 NEG 8.1 ± 0.1
493H 13.8 ± 0.3 21.8 ± 0.9 NEG 18.5 ± 0.2 7.2 ± 0.1
539T 16.8 ± 0.4 NEG 26.1 ± 1.8 NEG 8.9 ± 0.2
Poc NEG NEG NEG NEG 9.2 ± 0.7
Pow NEG NEG NEG NEG 20.3 ± 9.7
Pv NEG NEG NEG NEG 9.3 ± 0.4
Pm NEG NEG NEG NEG 9.5 ± 0.7
Pk1 NEG NEG NEG NEG 5.5 ± 0.1
Pk2 NEG NEG NEG NEG 6.3 ± 0.3
NTC NEG NEG NEG NEG NEG
aNo cross-reactivity with any human-infective Plasmodium. Published Pan-Plasmodium primer set50 was used as positive control. Samples tested
were: 580C1 (P. falciparumWT K13 sample 1), 580C2 (P. falciparumWT K13 sample 2), 580Y (P. falciparum K13 580Y), 493H (P. falciparum K13
493H), 539T (P. falciparum K13 539T), Poc (P. ovale curtisi), Pow (P. ovale wallikeri), Pv (P. vivax), Pm (P. malariae), Pk1 (P. knowlesi sample 1),
Pk2 (P. knowlesi sample 2), and NTC (non-template control). Experiment was performed in triplicates.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.8b02416
Anal. Chem. 2018, 90, 11972−11980
11977
Reverse-complement primers to FB/BB, named FA/BA,
located the SNP at the 3′ end in contrast to FB/BB which
located the SNP at the 5′ end. The 3′ end modiﬁed versions of
FB/BB and FA/BA, named FB*/BB* and FA*/BA*, included
an amino modiﬁcation which prevented the elongation of the
primers by the DNA polymerase. The results presented in
Figure 2C showed the similar behavior of the four primers in
combination with sbLAMP. This data proved for the ﬁrst time
that unmodiﬁed primers (FB/BB and FA/BA) can perform
similarly or better for allele-speciﬁc detection than modiﬁed
primers, based on statistical analysis. t test was performed to
compare the ΔTTP values obtained using modiﬁed and
unmodiﬁed primers with each template. In the case of the WT
template, FB/BB and FA/BA performed better than their
modiﬁed versions (p-value **** for both of them). In the case
of the MT template, FB/BB outperformed FB*/BB* (p-value
*), but no statistical signiﬁcance was observed for FA/BA and
FA*/BA*. Regarding the two sets of unmodiﬁed primers, FB/
BB presented higher ΔTTP values than FA/BA. Compared to
other strategies based on 3′ end chemical modiﬁcations,14,15,42
and the addition of mismatches at 3′ or 5′ end of FIP28 or
BIP,27 our methodology relies on total complementary
unmodiﬁed primers with extension capability. The easier
design and the lack of chemical modiﬁcations reduce the cost
of the assay and production time, positioning this method as a
promising molecular-based technique for SNP discrimination
to be used at PoC.
Guideline 3. Unmodiﬁed primers performed similarly or
better than 3′ end chemically modiﬁed primers to prevent
unspeciﬁc ampliﬁcation by sbLAMP, based on statistical
analysis. The use of FB/BB (SNP placed closed to the 5′
end) is recommended due to higher ΔTTP between speciﬁc
and unspeciﬁc reactions, easier design and lower cost and
production time.
Study of Diﬀerent Concentrations of USS Primers.
The selected USSWT FB127/BB221 and USSMT FB233/BB121
primers were added to the sbLAMP reaction mix at diﬀerent
concentrations: 1, 1.5, 2, 2.5, 3, 3.5, 4, and 4.5 μM. Real-time
ampliﬁcation experiments of WT and MT templates were
performed independently. For each template, WT and MT
reactions were tested (Figure 2D,E). Speciﬁc reactions were
slightly delayed as the concentration of the USS primers was
increased. The TTP values followed a linear ﬁt with slopes of
0.76 and 1.48 for the WT and the MT template, respectively.
Although the unspeciﬁc reactions also followed a linear ﬁt,
their slopes were sharper, denoting the signiﬁcance of the
concentration of FB/BB on delaying unspeciﬁc ampliﬁcation.
The TTP of speciﬁc and unspeciﬁc reactions was evaluated to
discern the optimum concentration of USS primers for allele
discrimination. Analyzing all the combinations of diﬀerent
concentrations, the one presenting the highest ΔTTP for both
templates without compromising the other was selected as the
optimum (Table S10). Selected concentrations were USSWT at
3 μM and USSMT at 4 μM.
Guideline 4. The concentration of USS primers in the
reaction mixture should be higher (preferably between 1.5× to
2.5×) than the concentrations of sbFIP and sbBIP, to not
compromise the limit of the detection of sbLAMP.
Sensitivity of USS-sbLAMP Method. Sensitivity was
tested using 10-fold serial dilutions (5 × 104, 5 × 103, 5 × 102,
and 5 × 101 copies/reaction) of WT and MT templates
independently (Figure 3A,C) for detection of SNP C580Y.
Ampliﬁcation curves are presented in Figure S2. For both
alleles, the detection limit was 5 × 101 copies/reaction within
30 min. Standard curves were generated with R2 values of
0.989 and 0.975, for WT and MT template, respectively,
denoting the ability of the assay to robustly quantify samples.
Pure WT and MT templates at concentrations below 5 × 103
and 5 × 104 copies/reaction, respectively, were uniquely
ampliﬁed by their corresponding speciﬁc reactions providing
“yes/no” results. Sensitivity of sbLAMP was not disrupted by
the incorporation of the USS primers, and ampliﬁcation of the
nontarget template was successfully delayed or inhibited. Two
reactions are always assessed (WT and MT reactions) for each
sample, providing two TTP values being one of them negative
at certain sample concentration (samples can be diluted if
needed). Consequently, having always two reactions ensures
the high speciﬁcity of the assay. Ampliﬁcation was performed
in less than 30 min at low DNA copies/reaction indicating the
rapidness achieved utilizing the USS-sbLAMP method
compared to other techniques based on PCR thermal cycling
such as molecular beacons, TaqMan or FRET,43,44 which
require complex designs, more than 1 h to ﬁnish and usually
postampliﬁcation analysis. Other reported isothermal assays
usually need between 20 to 75 min to ﬁnish,45,46 do not report
quantitative data,47 rely on the addition of probes (Au NPs) to
enhance speciﬁcity,48 lack ampliﬁcation data at low concen-
trations,26 or require sequencing for product speciﬁcity.49
Validation of the USS-sbLAMP Method with the
Artemisinin-Resistant SNP Y493H. Following the above
created guidelines for the design of USS-sbLAMP primers, a
speciﬁc USS-sbLAMP primer set was developed to detect a
second K13 SNP, Y439H (Table S2). USSMT-sbLAMPWT
primer set consisted of F1c21-B1c17 + FB224/BB126 at 4.5
μM and USSWT-sbLAMPMT primer set consisted of F1c21-
B1c17 + FB124/BB026 at 4.5 μM. Primer properties and
hybridization energies are provided in Table S11. Sensitivity
was tested using 10-fold serial dilutions (5 × 104, 5 × 103, 5 ×
102, and 5 × 101 copies/reaction) of WT and MT templates
independently (Figure 3B,C). Ampliﬁcation curves are
presented in Figure S3. For both alleles, the limit of detection
was 5 × 101 copies/reaction within 35 min. Standard curves
were generated with R2 values of 0.994 and 0.996, for WT and
MT template. Pure WT and MT templates at concentrations
below 5 × 104 copies/reaction and 5 × 105 copies/reaction,
respectively, were uniquely ampliﬁed by their corresponding
speciﬁc reactions.
Study of the USS-sbLAMP Method in Mixed
Populations Harboring SNPs C580Y and Y493H. USS-
sbLAMP primer sets for allele-speciﬁc detection of SNP C580Y
and SNP Y493H were evaluated with spiked mixed populations
at diﬀerent ratios (100/0, 80/20, 50/50, 20/80, and 0/100, in
percentages). The four alleles were clearly discriminated within
their respective speciﬁc reactions, as shown in Table 1.
Unspeciﬁc reactions did not amplify, demonstrating the
speciﬁcity of the method considering mixed populations at
80/20% as the limit for this experiment.
Cross-Validation of USS-sbLAMP Method for Detec-
tion of SNP C580Y and SNPY493H Using Clinical
Isolates. The speciﬁcity of USS-sbLAMP for detecting SNP
C580Y and Y493H was tested using gDNA samples from all
human-infective Plasmodium species: P. falciparum, P. ovale
curtisi, P. ovale wallikeri, P. vivax, P. malariae, and P. knowlesi, to
prove the absence of cross-reactivity with any of them. In
addition, three diﬀerent P. falciparum samples harboring the
mutations 580Y, 493H, and 539T were tested. There was no
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cross-reactivity with any of the human-infective Plasmodium
species (Table 2). The sample harboring the 539R mutation
was uniquely ampliﬁed by the WT reactions 580C and 493Y,
denoting the high speciﬁcity achieved by the MT reactions
580Y and 493H, which only ampliﬁed the samples harboring
their respective mutations.
■ CONCLUSION
The proposed USS-sbLAMP method achieves high sensitivity,
eﬃciency, speciﬁcity, and rapidness (TTP < 35 min) for the
detection of SNPs at isothermal conditions suitable for PoC
applications. For the ﬁrst time here, judiciously designed
sbLAMP primers for allele-speciﬁc ampliﬁcation are combined
with novel unmodiﬁed self-stabilizing (USS) competitive
primers speciﬁc to the SNP at their 5′ end which robustly
delay or prevent unspeciﬁc sbLAMP ampliﬁcation. The special
design, based on the local GC% content at the SNP position
enhanced allele speciﬁcity, and the superior concentration of
USS primers suppressed signiﬁcantly unspeciﬁc ampliﬁcation
oﬀering an excellent linear working range with a limit of
detection of 5 × 101 copies/reaction for the detection of two of
the most important artemisinin-resistant SNPs C580Y and
Y493H within 30 and 35 min, respectively. This universal
isothermal method uses chemically unmodiﬁed primers totally
complementary to the target template except at the SNP
position (either wild-type or mutant allele), which signiﬁcantly
reduces the cost of reagents and equipment avoiding the need
of thermal cycling and electrophoresis for product validation.
The guidelines we provide aim to enable others to develop
their own USS-sbLAMP primer sets to detect any kind of SNP,
which can relate to drug resistance, disease susceptibility or
cancer development. Diagnostic platforms that use CMOS-
based ISFET electrochemical biosensors,51,52 which identify
targets using pH-based nucleic acid ampliﬁcation, will perfectly
couple with the USS-sbLAMP method described here, with
eﬀorts currently underway to integrate these. Any diagnostic
device that can incorporate the proposed method will greatly
expand the capability of rapid SNP screening at PoC, including
LRS where infectious disease diagnosis and rapid drug
resistance screening are urgently needed.
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